Columbus, Ohio; Houston, Texas; and Chicago, Ill. From the Department of Plastic Surgery, The Ohio State University Wexner Medical Center; the Division of Plastic Surgery, Baylor College of Medicine; and Lakeview Plastic Surgery.
Plast Reconstr Surg. 2014 Jul;134(1):11-18. doi: 10.1097/PRS.0000000000000261.
Periprosthetic infection remains a frustrating and costly complication of breast reconstruction with tissue expanders. Although some specific steps have been previously shown to reduce periprosthetic infections, no comprehensive protocol addressing all aspects of preoperative, intraoperative, and postoperative patient management has been evaluated in the literature. The authors' goal was to evaluate the effectiveness of their protocol at reducing periprosthetic infections.
A comprehensive, best-practices protocol was introduced and implemented in November of 2010. All patients undergoing breast reconstruction using tissue expanders at the authors' institution in the 5 years before the protocol, and in the 2 years after, were analyzed.
Three hundred five patients underwent 456 tissue expander reconstructions in the 5 years before the protocol, and 198 patients underwent 313 reconstructions in the 2 years after. Significantly fewer patients developed periprosthetic infection after protocol (11.6 percent versus 18.4 percent; p=0.042), and the number of infected tissue expanders trended toward a decrease (9.3 percent versus 13.2 percent; p=0.097). On multivariate analysis, the protocol significantly reduced the odds of periprosthetic infection (OR, 0.45; p=0.022). Predictors of infection included obesity (OR, 2.01; p=0.045) and preoperative breast size larger than C cup (OR, 2.83; p=0.006).
The authors' comprehensive, best-practices protocol allowed them to reduce the odds of tissue expander infections by 55 percent (OR, 0.45; p=0.022). The authors were able to identify several potential areas of improvement that may help them lower the rate of infection further in the future.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
假体周围感染仍然是乳房重建中使用组织扩张器的令人沮丧且代价高昂的并发症。尽管以前已经显示出一些特定的步骤可以减少假体周围感染,但文献中尚未评估针对术前、术中、术后患者管理各个方面的综合方案。作者的目标是评估其方案在降低假体周围感染方面的有效性。
2010 年 11 月,引入并实施了一项全面的最佳实践方案。在方案实施前的 5 年中和方案实施后的 2 年内,对在作者所在机构接受组织扩张器乳房重建的所有患者进行了分析。
在方案实施前的 5 年中,有 305 名患者接受了 456 次组织扩张器重建,在方案实施后的 2 年中,有 198 名患者接受了 313 次重建。方案实施后,假体周围感染的患者明显减少(11.6%对 18.4%;p=0.042),感染的组织扩张器数量也呈下降趋势(9.3%对 13.2%;p=0.097)。多变量分析显示,该方案显著降低了假体周围感染的可能性(OR,0.45;p=0.022)。感染的预测因素包括肥胖(OR,2.01;p=0.045)和术前乳房大小大于 C 罩杯(OR,2.83;p=0.006)。
作者的综合最佳实践方案使他们能够将组织扩张器感染的可能性降低 55%(OR,0.45;p=0.022)。作者能够确定一些可能有助于他们在未来进一步降低感染率的改进领域。
临床问题/证据水平:治疗性,III 级。